Experimental Hematology Group - VHIO

VHIO’s Experimental Hematology Group conducts translational, pre-clinical and clinical research on hematological neoplasms of both lymphoid and myeloid origin. Our research team is composed of hematologists and biological scientists who work closely together to design, conduct and lead our programs.

Gaël Roué

Nirmatrelvir/ritonavir in COVID-19 patients with haematological

Early Clinical Drug Development Group - VHIO

Experimental Hematology Group - VHIO

CARsgen Announces Formation of its Clinical Advisory Board

VHIO and Catalan Blood & Tissue Bank trial to assess novel T-cell

Frontiers The relapsed acute lymphoblastic leukemia network

Carlota Pagès Geli - PHD Candidate - Vall d´Hebron Institute of

Hereditary Cancer Genetics Group - VHIO

Conservation of copy number profiles during engraftment and

Cancers, Free Full-Text

Tumor Biomarkers Group - VHIO

Different prognostic impact of recurrent gene mutations in chronic

PDF) Microenvironment regulates the expression of MIR-21 and tumor